scispace - formally typeset
S

Shoshana Paglin

Researcher at Sheba Medical Center

Publications -  21
Citations -  4149

Shoshana Paglin is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 11, co-authored 20 publications receiving 3965 citations. Previous affiliations of Shoshana Paglin include Memorial Sloan Kettering Cancer Center & Tel Aviv University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Daniel J. Klionsky, +235 more
- 16 Feb 2008 - 
TL;DR: A set of guidelines for the selection and interpretation of the methods that can be used by investigators who are attempting to examine macroautophagy and related processes, as well as by reviewers who need to provide realistic and reasonable critiques of papers that investigate these processes are presented.
Journal Article

A Novel Response of Cancer Cells to Radiation Involves Autophagy and Formation of Acidic Vesicles

TL;DR: The accretion of AVO in surviving progenies of irradiated cells, and the increased incidence of clonogenic death after inhibition of vacuolar H+-ATPase suggest that formation of acidic organelles represents a novel defense mechanism against radiation damage.
Journal ArticleDOI

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.

TL;DR: Findings show how Cy exerts its toxic effects on ovarian cells, as well as a potential method of protecting the ovaries and preserving fertility, and an experimental drug called AS101 shows potential as an ovarian-protective agent, which may be able to preserve fertility in female cancer patients.
Journal ArticleDOI

Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells

TL;DR: Radiation-induced inhibition of rapamycin-sensitive pathway and its effect on the cellular response to radiation were studied in the human breast cancer cell line MCF-7, showing changes in mitochondria metabolism, development of autophagy, and overall decrease in cell survival.
Journal Article

Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.

TL;DR: Data demonstrate that whereas bFGF inhibits the growth of several breast cancer cell lines, it concomitantly activates ERK1 and ERK2, generally considered to signal mitogenic rather than growth inhibitory responses.